September 14, 2023
Adagrasib Shows Enduring Activity in KRAS G12C+ Non–Small Cell Lung Cancer
Adagrasib shows promise in treating KRAS G12C-mutant NSCLC, with lasting responses and potential as a much-needed targeted therapy.
Cancer Network
Research News
Explore our curated selection of the latest breakthroughs in lung cancer research.
September 14, 2023
Adagrasib shows promise in treating KRAS G12C-mutant NSCLC, with lasting responses and potential as a much-needed targeted therapy.
Cancer Network
September 14, 2023
Study reveals 1 in 12 advanced lung cancer patients died from COVID-19 during the Omicron wave, highlighting the variant’s significant risk despite lower severity.
Cancer Therapy Advisor
September 12, 2023
At 22, Leah Hubbard faces advanced lung cancer potentially linked to teenage pregnancy, challenging assumptions about the disease and raising awareness.
The U.S. Sun
September 12, 2023
At the 2023 World Conference, lung cancer advocacy triumphed with a 25% funding boost for the Lung Cancer Research Program, thanks to strategic lobbying and a unified advocacy platform.
News Medical Life Sciences
September 12, 2023
Study reveals multiple pregnancies and extended breastfeeding reduce women’s lung cancer risk, suggesting reproductive factors influence cancer screening and prevention.
News Medical Life Sciences
September 12, 2023
Experts recommend enhanced lung cancer screening, accessible treatments, and increased research funding to prevent deaths and support affected individuals.
Mirage News
September 6, 2023
VA study reveals unique cancer patterns in Native American and Alaska Native veterans, informing tailored care and prevention efforts.
VA News
August 30, 2023
A study reveals that Black lung cancer patients are diagnosed younger and with more advanced stages than white patients, highlighting racial disparities in healthcare.
Health Day
August 18, 2023
New US guidelines lower lung cancer screening age to 50 and reduce smoking history requirement to 20 pack-years, expanding preventative scans to save more lives.
STAT
August 14, 2023
The FDA granted orphan drug status to Quratusugene ozeplasmid, a promising gene-based therapy for small cell lung cancer, to expedite its development.
OncLive
July 18, 2023
A recent multicenter study published in The Lancet highlights the promising efficacy of immunotherapy in advanced lung cancer patients.
The Lancet
July 18, 2023
The Monarch Platform robotic tool has revolutionized the way lung cancer is diagnosed and treated at Baptist Health. This cutting-edge technology provides a real-time, high-definition view of the airways, enabling doctors to identify and biopsy suspicious lung nodules with increased accuracy.
Becker's Hospital Review
Learn more about:
LCFA prioritizes providing reliable information about new diagnostics, treatments, and prevention strategies, including exciting FDA-approved personalized therapies based on individual tumor biomarkers. Human-reviewed, AI-created content is used to create some of the summaries for the articles listed.